NCT05710822 (peQasus) is a clinical trial of pulmonary vein isolation in Atrial Fibrillation, sponsored by University of Luebeck.

Who is sponsoring NCT05710822?

NCT05710822 is sponsored by University of Luebeck.

What drugs are being tested in NCT05710822?

Interventions in NCT05710822: pulmonary vein isolation.

What condition does NCT05710822 study?

NCT05710822 studies Atrial Fibrillation.

Is NCT05710822 still recruiting?

NCT05710822 is currently status unknown. Last updated 2 February 2023.

Last reviewed 2023-02-02 · How we verify

NCT05710822: peQasus

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study

Status unknown Last updated 2 February 2023

What this trial tests

trial testing pulmonary vein isolation in Atrial Fibrillation in 300 participants. Status unknown.

Timeline

31 January 2023

Primary endpoint
30 June 2023

30 June 2023

Quick facts

Lead sponsor	University of Luebeck
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	31 January 2023
Primary completion	30 June 2023
Estimated completion	30 June 2023

Drugs / interventions tested

pulmonary vein isolation

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

University of Luebeck

Who can join

Eligibility, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PeQasus is a worldwide, retrospective, multicenter analysis focusing on QDOT based PVI. Data of at least 300 patients with QDOT based PVI will be collected. All data will be evaluated after anonymization. Primary endoints are efficacy and safety.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Temperature-guided high and very high-power short duration ablation for atrial fibrillation treatment: the peQasus multicentre study.
Heeger CH, Almorad A, Scherr D, Szegedi N, et al · · 2025 · cited 10× · PMID 39504572 · DOI 10.1093/europace/euae284

Verify or expand the search:

Other trials of pulmonary vein isolation

Trials testing the same drug.

NCT04503122 — Baroreflex Sensitivity in Patients Undergoing Ablation of Atrial Fibrillation · completed
NCT05081310 — Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation · NA · unknown
NCT05870306 — Triple Atria Extrastimuli vs Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation · NA · active not recruiting
NCT03046043 — AF Ablation Based on High Density Voltage Mapping and CFAE · NA · completed
NCT03242694 — Left Atrial Function Analysis for Patients With Persistent Atrial Fibrillation Undergoing Pulmonary Vein Isolation · unknown

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other University of Luebeck trials

Trials by the same sponsor.

NCT06598280 — Same-Day Discharge Versus Overnight Stay Following Pulmonary Vein Isolation for Atrial Fibrillation · NA · recruiting
NCT06493994 — Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry · recruiting
NCT05846412 — Treatment of Functional Mitral Regurgitation in Patients With Atrial Fibrillation · NA · unknown
NCT05563142 — Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation · NA · completed
NCT05390047 — The International SubcutaneouS Implantable Cardioverter Defibrillator Registry (iSuSI) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05710822 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Luebeck
Last refreshed: 2 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05710822.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing